- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe dry eye syndrome, including Sjogren's syndrome
- Meeting Date: July 2022
- Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 359KB)
- Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 56KB)
Polyethylene glycol 400 with propylene glycol – July 2022
Polyethylene glycol 400 with propylene glycol: Eye drops 4 mg-3 mg per mL, 15 mL; Optix®
Last updated
28 October 2022